nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—epilepsy syndrome	0.195	0.532	CbGaD
Pomalidomide—PTGS2—epilepsy syndrome	0.0927	0.253	CbGaD
Pomalidomide—ABCB1—epilepsy syndrome	0.0788	0.215	CbGaD
Pomalidomide—ABCB1—Levetiracetam—epilepsy syndrome	0.0268	0.0701	CbGbCtD
Pomalidomide—ABCB1—Clobazam—epilepsy syndrome	0.0186	0.0486	CbGbCtD
Pomalidomide—ABCB1—Lamotrigine—epilepsy syndrome	0.0179	0.0468	CbGbCtD
Pomalidomide—CYP1A2—Carbamazepine—epilepsy syndrome	0.0176	0.046	CbGbCtD
Pomalidomide—CYP1A2—Primidone—epilepsy syndrome	0.0165	0.043	CbGbCtD
Pomalidomide—ABCB1—Carbamazepine—epilepsy syndrome	0.0154	0.0402	CbGbCtD
Pomalidomide—CYP1A2—Propofol—epilepsy syndrome	0.0148	0.0385	CbGbCtD
Pomalidomide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0147	0.0384	CbGbCtD
Pomalidomide—CYP1A2—Phenobarbital—epilepsy syndrome	0.0141	0.0368	CbGbCtD
Pomalidomide—ABCB1—Phenytoin—epilepsy syndrome	0.0138	0.0361	CbGbCtD
Pomalidomide—CYP3A4—Trimethadione—epilepsy syndrome	0.0137	0.0357	CbGbCtD
Pomalidomide—CYP3A4—Felbamate—epilepsy syndrome	0.0137	0.0357	CbGbCtD
Pomalidomide—CYP1A2—Diazepam—epilepsy syndrome	0.0134	0.0349	CbGbCtD
Pomalidomide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0129	0.0336	CbGbCtD
Pomalidomide—ABCB1—Phenobarbital—epilepsy syndrome	0.0123	0.0322	CbGbCtD
Pomalidomide—ABCB1—Midazolam—epilepsy syndrome	0.0122	0.0317	CbGbCtD
Pomalidomide—ABCB1—Diazepam—epilepsy syndrome	0.0117	0.0305	CbGbCtD
Pomalidomide—CYP3A4—Clonazepam—epilepsy syndrome	0.0116	0.0304	CbGbCtD
Pomalidomide—CYP3A4—Clobazam—epilepsy syndrome	0.0111	0.0291	CbGbCtD
Pomalidomide—CYP1A2—Valproic Acid—epilepsy syndrome	0.0105	0.0275	CbGbCtD
Pomalidomide—CYP3A4—Rufinamide—epilepsy syndrome	0.00948	0.0247	CbGbCtD
Pomalidomide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00924	0.0241	CbGbCtD
Pomalidomide—CYP3A4—Primidone—epilepsy syndrome	0.00862	0.0225	CbGbCtD
Pomalidomide—CYP3A4—Phenytoin—epilepsy syndrome	0.00829	0.0216	CbGbCtD
Pomalidomide—CYP3A4—Propofol—epilepsy syndrome	0.00773	0.0202	CbGbCtD
Pomalidomide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00739	0.0193	CbGbCtD
Pomalidomide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00739	0.0193	CbGbCtD
Pomalidomide—CYP3A4—Midazolam—epilepsy syndrome	0.00728	0.019	CbGbCtD
Pomalidomide—CYP3A4—Diazepam—epilepsy syndrome	0.007	0.0183	CbGbCtD
Pomalidomide—CYP3A4—Zonisamide—epilepsy syndrome	0.00683	0.0178	CbGbCtD
Pomalidomide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00552	0.0144	CbGbCtD
Pomalidomide—CYP3A4—Topiramate—epilepsy syndrome	0.00498	0.013	CbGbCtD
Pomalidomide—Thalidomide—TNF—epilepsy syndrome	0.000712	0.27	CrCbGaD
Pomalidomide—CRBN—forebrain—epilepsy syndrome	0.000566	0.104	CbGeAlD
Pomalidomide—Lenalidomide—PTGS2—epilepsy syndrome	0.000565	0.214	CrCbGaD
Pomalidomide—Thalidomide—CYP2C19—epilepsy syndrome	0.000543	0.206	CrCbGaD
Pomalidomide—CRBN—telencephalon—epilepsy syndrome	0.00052	0.0955	CbGeAlD
Pomalidomide—Lenalidomide—ABCB1—epilepsy syndrome	0.00048	0.182	CrCbGaD
Pomalidomide—CRBN—medulla oblongata—epilepsy syndrome	0.000409	0.075	CbGeAlD
Pomalidomide—CRBN—midbrain—epilepsy syndrome	0.000374	0.0686	CbGeAlD
Pomalidomide—CRBN—spinal cord—epilepsy syndrome	0.000365	0.0669	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—epilepsy syndrome	0.000338	0.128	CrCbGaD
Pomalidomide—CRBN—head—epilepsy syndrome	0.000324	0.0594	CbGeAlD
Pomalidomide—CRBN—nervous system—epilepsy syndrome	0.000307	0.0564	CbGeAlD
Pomalidomide—CRBN—central nervous system—epilepsy syndrome	0.000296	0.0543	CbGeAlD
Pomalidomide—CRBN—cerebellum—epilepsy syndrome	0.000289	0.053	CbGeAlD
Pomalidomide—CRBN—brain—epilepsy syndrome	0.000235	0.0431	CbGeAlD
Pomalidomide—PTGS2—forebrain—epilepsy syndrome	0.000154	0.0283	CbGeAlD
Pomalidomide—PTGS2—telencephalon—epilepsy syndrome	0.000142	0.026	CbGeAlD
Pomalidomide—PTGS2—medulla oblongata—epilepsy syndrome	0.000111	0.0204	CbGeAlD
Pomalidomide—PTGS2—midbrain—epilepsy syndrome	0.000102	0.0187	CbGeAlD
Pomalidomide—PTGS2—spinal cord—epilepsy syndrome	9.92e-05	0.0182	CbGeAlD
Pomalidomide—ABCB1—forebrain—epilepsy syndrome	9.53e-05	0.0175	CbGeAlD
Pomalidomide—PTGS2—head—epilepsy syndrome	8.82e-05	0.0162	CbGeAlD
Pomalidomide—ABCB1—telencephalon—epilepsy syndrome	8.76e-05	0.0161	CbGeAlD
Pomalidomide—PTGS2—nervous system—epilepsy syndrome	8.36e-05	0.0153	CbGeAlD
Pomalidomide—Vomiting—Midazolam—epilepsy syndrome	8.1e-05	0.000473	CcSEcCtD
Pomalidomide—Diarrhoea—Vigabatrin—epilepsy syndrome	8.1e-05	0.000473	CcSEcCtD
Pomalidomide—Asthenia—Felbamate—epilepsy syndrome	8.09e-05	0.000472	CcSEcCtD
Pomalidomide—Arthralgia—Valproic Acid—epilepsy syndrome	8.08e-05	0.000472	CcSEcCtD
Pomalidomide—Anxiety—Valproic Acid—epilepsy syndrome	8.05e-05	0.00047	CcSEcCtD
Pomalidomide—PTGS2—central nervous system—epilepsy syndrome	8.05e-05	0.0148	CbGeAlD
Pomalidomide—Tremor—Pregabalin—epilepsy syndrome	8.04e-05	0.000469	CcSEcCtD
Pomalidomide—Feeling abnormal—Lamotrigine—epilepsy syndrome	8.03e-05	0.000469	CcSEcCtD
Pomalidomide—Rash—Midazolam—epilepsy syndrome	8.03e-05	0.000469	CcSEcCtD
Pomalidomide—Dizziness—Fosphenytoin—epilepsy syndrome	8.03e-05	0.000469	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	8.02e-05	0.000468	CcSEcCtD
Pomalidomide—Dermatitis—Midazolam—epilepsy syndrome	8.02e-05	0.000468	CcSEcCtD
Pomalidomide—Vomiting—Levetiracetam—epilepsy syndrome	8e-05	0.000467	CcSEcCtD
Pomalidomide—Epistaxis—Topiramate—epilepsy syndrome	7.99e-05	0.000466	CcSEcCtD
Pomalidomide—Headache—Midazolam—epilepsy syndrome	7.98e-05	0.000466	CcSEcCtD
Pomalidomide—Pruritus—Felbamate—epilepsy syndrome	7.98e-05	0.000466	CcSEcCtD
Pomalidomide—Body temperature increased—Carbamazepine—epilepsy syndrome	7.97e-05	0.000465	CcSEcCtD
Pomalidomide—Diarrhoea—Diazepam—epilepsy syndrome	7.97e-05	0.000465	CcSEcCtD
Pomalidomide—Rash—Levetiracetam—epilepsy syndrome	7.93e-05	0.000463	CcSEcCtD
Pomalidomide—Anaemia—Pregabalin—epilepsy syndrome	7.93e-05	0.000463	CcSEcCtD
Pomalidomide—Dermatitis—Levetiracetam—epilepsy syndrome	7.92e-05	0.000463	CcSEcCtD
Pomalidomide—Asthenia—Zonisamide—epilepsy syndrome	7.92e-05	0.000462	CcSEcCtD
Pomalidomide—Mental disorder—Gabapentin—epilepsy syndrome	7.92e-05	0.000462	CcSEcCtD
Pomalidomide—Headache—Levetiracetam—epilepsy syndrome	7.88e-05	0.00046	CcSEcCtD
Pomalidomide—PTGS2—cerebellum—epilepsy syndrome	7.87e-05	0.0144	CbGeAlD
Pomalidomide—Malnutrition—Gabapentin—epilepsy syndrome	7.87e-05	0.000459	CcSEcCtD
Pomalidomide—Hypersensitivity—Clonazepam—epilepsy syndrome	7.84e-05	0.000457	CcSEcCtD
Pomalidomide—Dizziness—Vigabatrin—epilepsy syndrome	7.83e-05	0.000457	CcSEcCtD
Pomalidomide—Confusional state—Valproic Acid—epilepsy syndrome	7.81e-05	0.000456	CcSEcCtD
Pomalidomide—Pruritus—Zonisamide—epilepsy syndrome	7.81e-05	0.000456	CcSEcCtD
Pomalidomide—Hypersensitivity—Phenytoin—epilepsy syndrome	7.78e-05	0.000454	CcSEcCtD
Pomalidomide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.74e-05	0.000452	CcSEcCtD
Pomalidomide—Nausea—Propofol—epilepsy syndrome	7.73e-05	0.000451	CcSEcCtD
Pomalidomide—Vomiting—Fosphenytoin—epilepsy syndrome	7.72e-05	0.000451	CcSEcCtD
Pomalidomide—Diarrhoea—Felbamate—epilepsy syndrome	7.71e-05	0.00045	CcSEcCtD
Pomalidomide—Vertigo—Pregabalin—epilepsy syndrome	7.71e-05	0.00045	CcSEcCtD
Pomalidomide—Body temperature increased—Lamotrigine—epilepsy syndrome	7.71e-05	0.00045	CcSEcCtD
Pomalidomide—Dizziness—Diazepam—epilepsy syndrome	7.7e-05	0.00045	CcSEcCtD
Pomalidomide—Infection—Valproic Acid—epilepsy syndrome	7.69e-05	0.000449	CcSEcCtD
Pomalidomide—Leukopenia—Pregabalin—epilepsy syndrome	7.68e-05	0.000448	CcSEcCtD
Pomalidomide—Rash—Fosphenytoin—epilepsy syndrome	7.65e-05	0.000447	CcSEcCtD
Pomalidomide—Dermatitis—Fosphenytoin—epilepsy syndrome	7.65e-05	0.000446	CcSEcCtD
Pomalidomide—Asthenia—Clonazepam—epilepsy syndrome	7.63e-05	0.000445	CcSEcCtD
Pomalidomide—Back pain—Gabapentin—epilepsy syndrome	7.61e-05	0.000444	CcSEcCtD
Pomalidomide—Headache—Fosphenytoin—epilepsy syndrome	7.61e-05	0.000444	CcSEcCtD
Pomalidomide—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.6e-05	0.000443	CcSEcCtD
Pomalidomide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	7.58e-05	0.000443	CcSEcCtD
Pomalidomide—Asthenia—Phenytoin—epilepsy syndrome	7.58e-05	0.000443	CcSEcCtD
Pomalidomide—Nausea—Midazolam—epilepsy syndrome	7.57e-05	0.000442	CcSEcCtD
Pomalidomide—Muscle spasms—Gabapentin—epilepsy syndrome	7.56e-05	0.000442	CcSEcCtD
Pomalidomide—Diarrhoea—Zonisamide—epilepsy syndrome	7.55e-05	0.000441	CcSEcCtD
Pomalidomide—Asthenia—Oxcarbazepine—epilepsy syndrome	7.54e-05	0.00044	CcSEcCtD
Pomalidomide—Pruritus—Clonazepam—epilepsy syndrome	7.53e-05	0.000439	CcSEcCtD
Pomalidomide—Vomiting—Vigabatrin—epilepsy syndrome	7.52e-05	0.000439	CcSEcCtD
Pomalidomide—Skin disorder—Valproic Acid—epilepsy syndrome	7.52e-05	0.000439	CcSEcCtD
Pomalidomide—Urinary tract disorder—Topiramate—epilepsy syndrome	7.51e-05	0.000438	CcSEcCtD
Pomalidomide—Oedema peripheral—Topiramate—epilepsy syndrome	7.49e-05	0.000437	CcSEcCtD
Pomalidomide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	7.49e-05	0.000437	CcSEcCtD
Pomalidomide—Cough—Pregabalin—epilepsy syndrome	7.49e-05	0.000437	CcSEcCtD
Pomalidomide—Pruritus—Phenytoin—epilepsy syndrome	7.48e-05	0.000436	CcSEcCtD
Pomalidomide—Connective tissue disorder—Topiramate—epilepsy syndrome	7.47e-05	0.000436	CcSEcCtD
Pomalidomide—Nausea—Levetiracetam—epilepsy syndrome	7.47e-05	0.000436	CcSEcCtD
Pomalidomide—Rash—Vigabatrin—epilepsy syndrome	7.46e-05	0.000436	CcSEcCtD
Pomalidomide—Dizziness—Felbamate—epilepsy syndrome	7.46e-05	0.000435	CcSEcCtD
Pomalidomide—Dermatitis—Vigabatrin—epilepsy syndrome	7.45e-05	0.000435	CcSEcCtD
Pomalidomide—Urethral disorder—Topiramate—epilepsy syndrome	7.45e-05	0.000435	CcSEcCtD
Pomalidomide—Pruritus—Oxcarbazepine—epilepsy syndrome	7.44e-05	0.000434	CcSEcCtD
Pomalidomide—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.43e-05	0.000434	CcSEcCtD
Pomalidomide—Headache—Vigabatrin—epilepsy syndrome	7.41e-05	0.000433	CcSEcCtD
Pomalidomide—Vomiting—Diazepam—epilepsy syndrome	7.41e-05	0.000432	CcSEcCtD
Pomalidomide—Tremor—Gabapentin—epilepsy syndrome	7.37e-05	0.00043	CcSEcCtD
Pomalidomide—Rash—Diazepam—epilepsy syndrome	7.35e-05	0.000429	CcSEcCtD
Pomalidomide—Dermatitis—Diazepam—epilepsy syndrome	7.34e-05	0.000428	CcSEcCtD
Pomalidomide—CYP3A4—nervous system—epilepsy syndrome	7.31e-05	0.0134	CbGeAlD
Pomalidomide—Arthralgia—Pregabalin—epilepsy syndrome	7.3e-05	0.000426	CcSEcCtD
Pomalidomide—Dizziness—Zonisamide—epilepsy syndrome	7.3e-05	0.000426	CcSEcCtD
Pomalidomide—Headache—Diazepam—epilepsy syndrome	7.3e-05	0.000426	CcSEcCtD
Pomalidomide—Anxiety—Pregabalin—epilepsy syndrome	7.28e-05	0.000425	CcSEcCtD
Pomalidomide—Diarrhoea—Clonazepam—epilepsy syndrome	7.28e-05	0.000425	CcSEcCtD
Pomalidomide—Anaemia—Gabapentin—epilepsy syndrome	7.27e-05	0.000424	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.25e-05	0.000423	CcSEcCtD
Pomalidomide—Asthenia—Carbamazepine—epilepsy syndrome	7.24e-05	0.000422	CcSEcCtD
Pomalidomide—Diarrhoea—Phenytoin—epilepsy syndrome	7.23e-05	0.000422	CcSEcCtD
Pomalidomide—Nausea—Fosphenytoin—epilepsy syndrome	7.21e-05	0.000421	CcSEcCtD
Pomalidomide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.19e-05	0.00042	CcSEcCtD
Pomalidomide—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.18e-05	0.000419	CcSEcCtD
Pomalidomide—Vomiting—Felbamate—epilepsy syndrome	7.17e-05	0.000418	CcSEcCtD
Pomalidomide—Pruritus—Carbamazepine—epilepsy syndrome	7.14e-05	0.000417	CcSEcCtD
Pomalidomide—Rash—Felbamate—epilepsy syndrome	7.11e-05	0.000415	CcSEcCtD
Pomalidomide—Dermatitis—Felbamate—epilepsy syndrome	7.1e-05	0.000415	CcSEcCtD
Pomalidomide—Vertigo—Gabapentin—epilepsy syndrome	7.07e-05	0.000413	CcSEcCtD
Pomalidomide—Headache—Felbamate—epilepsy syndrome	7.06e-05	0.000412	CcSEcCtD
Pomalidomide—Confusional state—Pregabalin—epilepsy syndrome	7.06e-05	0.000412	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.06e-05	0.000412	CcSEcCtD
Pomalidomide—Cardiac disorder—Topiramate—epilepsy syndrome	7.06e-05	0.000412	CcSEcCtD
Pomalidomide—Leukopenia—Gabapentin—epilepsy syndrome	7.04e-05	0.000411	CcSEcCtD
Pomalidomide—CYP3A4—central nervous system—epilepsy syndrome	7.04e-05	0.0129	CbGeAlD
Pomalidomide—Dizziness—Clonazepam—epilepsy syndrome	7.03e-05	0.000411	CcSEcCtD
Pomalidomide—Nausea—Vigabatrin—epilepsy syndrome	7.03e-05	0.00041	CcSEcCtD
Pomalidomide—Vomiting—Zonisamide—epilepsy syndrome	7.02e-05	0.00041	CcSEcCtD
Pomalidomide—Insomnia—Valproic Acid—epilepsy syndrome	7.01e-05	0.000409	CcSEcCtD
Pomalidomide—Asthenia—Lamotrigine—epilepsy syndrome	6.99e-05	0.000408	CcSEcCtD
Pomalidomide—Dizziness—Phenytoin—epilepsy syndrome	6.99e-05	0.000408	CcSEcCtD
Pomalidomide—Rash—Zonisamide—epilepsy syndrome	6.96e-05	0.000406	CcSEcCtD
Pomalidomide—Infection—Pregabalin—epilepsy syndrome	6.96e-05	0.000406	CcSEcCtD
Pomalidomide—Dermatitis—Zonisamide—epilepsy syndrome	6.95e-05	0.000406	CcSEcCtD
Pomalidomide—Dizziness—Oxcarbazepine—epilepsy syndrome	6.95e-05	0.000406	CcSEcCtD
Pomalidomide—Nausea—Diazepam—epilepsy syndrome	6.92e-05	0.000404	CcSEcCtD
Pomalidomide—Headache—Zonisamide—epilepsy syndrome	6.91e-05	0.000404	CcSEcCtD
Pomalidomide—Dyspnoea—Valproic Acid—epilepsy syndrome	6.91e-05	0.000403	CcSEcCtD
Pomalidomide—Diarrhoea—Carbamazepine—epilepsy syndrome	6.9e-05	0.000403	CcSEcCtD
Pomalidomide—Angiopathy—Topiramate—epilepsy syndrome	6.9e-05	0.000403	CcSEcCtD
Pomalidomide—Pruritus—Lamotrigine—epilepsy syndrome	6.9e-05	0.000403	CcSEcCtD
Pomalidomide—ABCB1—medulla oblongata—epilepsy syndrome	6.88e-05	0.0126	CbGeAlD
Pomalidomide—Nervous system disorder—Pregabalin—epilepsy syndrome	6.87e-05	0.000401	CcSEcCtD
Pomalidomide—Cough—Gabapentin—epilepsy syndrome	6.87e-05	0.000401	CcSEcCtD
Pomalidomide—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.86e-05	0.0004	CcSEcCtD
Pomalidomide—Mediastinal disorder—Topiramate—epilepsy syndrome	6.85e-05	0.0004	CcSEcCtD
Pomalidomide—Chills—Topiramate—epilepsy syndrome	6.82e-05	0.000398	CcSEcCtD
Pomalidomide—Skin disorder—Pregabalin—epilepsy syndrome	6.8e-05	0.000397	CcSEcCtD
Pomalidomide—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.77e-05	0.000395	CcSEcCtD
Pomalidomide—Vomiting—Clonazepam—epilepsy syndrome	6.76e-05	0.000395	CcSEcCtD
Pomalidomide—Decreased appetite—Valproic Acid—epilepsy syndrome	6.73e-05	0.000393	CcSEcCtD
Pomalidomide—Vomiting—Phenytoin—epilepsy syndrome	6.72e-05	0.000392	CcSEcCtD
Pomalidomide—Rash—Clonazepam—epilepsy syndrome	6.71e-05	0.000392	CcSEcCtD
Pomalidomide—Dermatitis—Clonazepam—epilepsy syndrome	6.7e-05	0.000391	CcSEcCtD
Pomalidomide—Arthralgia—Gabapentin—epilepsy syndrome	6.7e-05	0.000391	CcSEcCtD
Pomalidomide—Nausea—Felbamate—epilepsy syndrome	6.7e-05	0.000391	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.69e-05	0.00039	CcSEcCtD
Pomalidomide—Vomiting—Oxcarbazepine—epilepsy syndrome	6.68e-05	0.00039	CcSEcCtD
Pomalidomide—Fatigue—Valproic Acid—epilepsy syndrome	6.68e-05	0.00039	CcSEcCtD
Pomalidomide—Anxiety—Gabapentin—epilepsy syndrome	6.67e-05	0.00039	CcSEcCtD
Pomalidomide—Dizziness—Carbamazepine—epilepsy syndrome	6.67e-05	0.000389	CcSEcCtD
Pomalidomide—Diarrhoea—Lamotrigine—epilepsy syndrome	6.67e-05	0.000389	CcSEcCtD
Pomalidomide—Headache—Clonazepam—epilepsy syndrome	6.66e-05	0.000389	CcSEcCtD
Pomalidomide—Rash—Phenytoin—epilepsy syndrome	6.66e-05	0.000389	CcSEcCtD
Pomalidomide—Mental disorder—Topiramate—epilepsy syndrome	6.66e-05	0.000389	CcSEcCtD
Pomalidomide—Dermatitis—Phenytoin—epilepsy syndrome	6.66e-05	0.000389	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.65e-05	0.000388	CcSEcCtD
Pomalidomide—Rash—Oxcarbazepine—epilepsy syndrome	6.63e-05	0.000387	CcSEcCtD
Pomalidomide—Constipation—Valproic Acid—epilepsy syndrome	6.62e-05	0.000387	CcSEcCtD
Pomalidomide—Pain—Valproic Acid—epilepsy syndrome	6.62e-05	0.000387	CcSEcCtD
Pomalidomide—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.62e-05	0.000386	CcSEcCtD
Pomalidomide—Headache—Phenytoin—epilepsy syndrome	6.62e-05	0.000386	CcSEcCtD
Pomalidomide—Malnutrition—Topiramate—epilepsy syndrome	6.62e-05	0.000386	CcSEcCtD
Pomalidomide—Headache—Oxcarbazepine—epilepsy syndrome	6.58e-05	0.000384	CcSEcCtD
Pomalidomide—Nausea—Zonisamide—epilepsy syndrome	6.56e-05	0.000383	CcSEcCtD
Pomalidomide—Confusional state—Gabapentin—epilepsy syndrome	6.47e-05	0.000378	CcSEcCtD
Pomalidomide—Dizziness—Lamotrigine—epilepsy syndrome	6.45e-05	0.000376	CcSEcCtD
Pomalidomide—Vomiting—Carbamazepine—epilepsy syndrome	6.41e-05	0.000374	CcSEcCtD
Pomalidomide—Back pain—Topiramate—epilepsy syndrome	6.4e-05	0.000374	CcSEcCtD
Pomalidomide—PTGS2—brain—epilepsy syndrome	6.39e-05	0.0117	CbGeAlD
Pomalidomide—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.38e-05	0.000373	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.38e-05	0.000372	CcSEcCtD
Pomalidomide—Infection—Gabapentin—epilepsy syndrome	6.38e-05	0.000372	CcSEcCtD
Pomalidomide—Muscle spasms—Topiramate—epilepsy syndrome	6.36e-05	0.000371	CcSEcCtD
Pomalidomide—Rash—Carbamazepine—epilepsy syndrome	6.36e-05	0.000371	CcSEcCtD
Pomalidomide—Dermatitis—Carbamazepine—epilepsy syndrome	6.35e-05	0.000371	CcSEcCtD
Pomalidomide—Insomnia—Pregabalin—epilepsy syndrome	6.33e-05	0.00037	CcSEcCtD
Pomalidomide—Nausea—Clonazepam—epilepsy syndrome	6.32e-05	0.000369	CcSEcCtD
Pomalidomide—Headache—Carbamazepine—epilepsy syndrome	6.32e-05	0.000369	CcSEcCtD
Pomalidomide—Nervous system disorder—Gabapentin—epilepsy syndrome	6.3e-05	0.000368	CcSEcCtD
Pomalidomide—ABCB1—midbrain—epilepsy syndrome	6.29e-05	0.0115	CbGeAlD
Pomalidomide—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.29e-05	0.000367	CcSEcCtD
Pomalidomide—Nausea—Phenytoin—epilepsy syndrome	6.28e-05	0.000366	CcSEcCtD
Pomalidomide—Dyspnoea—Pregabalin—epilepsy syndrome	6.24e-05	0.000364	CcSEcCtD
Pomalidomide—Nausea—Oxcarbazepine—epilepsy syndrome	6.24e-05	0.000364	CcSEcCtD
Pomalidomide—Skin disorder—Gabapentin—epilepsy syndrome	6.24e-05	0.000364	CcSEcCtD
Pomalidomide—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.21e-05	0.000362	CcSEcCtD
Pomalidomide—Tremor—Topiramate—epilepsy syndrome	6.2e-05	0.000362	CcSEcCtD
Pomalidomide—Vomiting—Lamotrigine—epilepsy syndrome	6.2e-05	0.000362	CcSEcCtD
Pomalidomide—Rash—Lamotrigine—epilepsy syndrome	6.15e-05	0.000359	CcSEcCtD
Pomalidomide—Dermatitis—Lamotrigine—epilepsy syndrome	6.14e-05	0.000358	CcSEcCtD
Pomalidomide—ABCB1—spinal cord—epilepsy syndrome	6.14e-05	0.0113	CbGeAlD
Pomalidomide—Body temperature increased—Valproic Acid—epilepsy syndrome	6.12e-05	0.000357	CcSEcCtD
Pomalidomide—Anaemia—Topiramate—epilepsy syndrome	6.12e-05	0.000357	CcSEcCtD
Pomalidomide—Headache—Lamotrigine—epilepsy syndrome	6.11e-05	0.000356	CcSEcCtD
Pomalidomide—Decreased appetite—Pregabalin—epilepsy syndrome	6.09e-05	0.000355	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.05e-05	0.000353	CcSEcCtD
Pomalidomide—Fatigue—Pregabalin—epilepsy syndrome	6.04e-05	0.000352	CcSEcCtD
Pomalidomide—Nausea—Carbamazepine—epilepsy syndrome	5.99e-05	0.00035	CcSEcCtD
Pomalidomide—Pain—Pregabalin—epilepsy syndrome	5.99e-05	0.00035	CcSEcCtD
Pomalidomide—Constipation—Pregabalin—epilepsy syndrome	5.99e-05	0.00035	CcSEcCtD
Pomalidomide—Vertigo—Topiramate—epilepsy syndrome	5.95e-05	0.000347	CcSEcCtD
Pomalidomide—Leukopenia—Topiramate—epilepsy syndrome	5.92e-05	0.000346	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.85e-05	0.000341	CcSEcCtD
Pomalidomide—Insomnia—Gabapentin—epilepsy syndrome	5.81e-05	0.000339	CcSEcCtD
Pomalidomide—Nausea—Lamotrigine—epilepsy syndrome	5.79e-05	0.000338	CcSEcCtD
Pomalidomide—Cough—Topiramate—epilepsy syndrome	5.78e-05	0.000337	CcSEcCtD
Pomalidomide—Feeling abnormal—Pregabalin—epilepsy syndrome	5.77e-05	0.000337	CcSEcCtD
Pomalidomide—Dyspnoea—Gabapentin—epilepsy syndrome	5.72e-05	0.000334	CcSEcCtD
Pomalidomide—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.71e-05	0.000333	CcSEcCtD
Pomalidomide—Arthralgia—Topiramate—epilepsy syndrome	5.64e-05	0.000329	CcSEcCtD
Pomalidomide—Anxiety—Topiramate—epilepsy syndrome	5.62e-05	0.000328	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.6e-05	0.000327	CcSEcCtD
Pomalidomide—Decreased appetite—Gabapentin—epilepsy syndrome	5.58e-05	0.000326	CcSEcCtD
Pomalidomide—Asthenia—Valproic Acid—epilepsy syndrome	5.56e-05	0.000324	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.54e-05	0.000324	CcSEcCtD
Pomalidomide—Fatigue—Gabapentin—epilepsy syndrome	5.54e-05	0.000323	CcSEcCtD
Pomalidomide—Body temperature increased—Pregabalin—epilepsy syndrome	5.54e-05	0.000323	CcSEcCtD
Pomalidomide—Constipation—Gabapentin—epilepsy syndrome	5.49e-05	0.000321	CcSEcCtD
Pomalidomide—Pain—Gabapentin—epilepsy syndrome	5.49e-05	0.000321	CcSEcCtD
Pomalidomide—Pruritus—Valproic Acid—epilepsy syndrome	5.48e-05	0.00032	CcSEcCtD
Pomalidomide—ABCB1—head—epilepsy syndrome	5.46e-05	0.01	CbGeAlD
Pomalidomide—Confusional state—Topiramate—epilepsy syndrome	5.45e-05	0.000318	CcSEcCtD
Pomalidomide—Infection—Topiramate—epilepsy syndrome	5.37e-05	0.000313	CcSEcCtD
Pomalidomide—Diarrhoea—Valproic Acid—epilepsy syndrome	5.3e-05	0.000309	CcSEcCtD
Pomalidomide—Nervous system disorder—Topiramate—epilepsy syndrome	5.3e-05	0.000309	CcSEcCtD
Pomalidomide—Feeling abnormal—Gabapentin—epilepsy syndrome	5.29e-05	0.000309	CcSEcCtD
Pomalidomide—Thrombocytopenia—Topiramate—epilepsy syndrome	5.29e-05	0.000309	CcSEcCtD
Pomalidomide—Skin disorder—Topiramate—epilepsy syndrome	5.25e-05	0.000306	CcSEcCtD
Pomalidomide—Hyperhidrosis—Topiramate—epilepsy syndrome	5.22e-05	0.000305	CcSEcCtD
Pomalidomide—ABCB1—nervous system—epilepsy syndrome	5.17e-05	0.00949	CbGeAlD
Pomalidomide—Hypersensitivity—Pregabalin—epilepsy syndrome	5.16e-05	0.000301	CcSEcCtD
Pomalidomide—Dizziness—Valproic Acid—epilepsy syndrome	5.12e-05	0.000299	CcSEcCtD
Pomalidomide—Body temperature increased—Gabapentin—epilepsy syndrome	5.08e-05	0.000296	CcSEcCtD
Pomalidomide—Asthenia—Pregabalin—epilepsy syndrome	5.02e-05	0.000293	CcSEcCtD
Pomalidomide—ABCB1—central nervous system—epilepsy syndrome	4.98e-05	0.00914	CbGeAlD
Pomalidomide—Pruritus—Pregabalin—epilepsy syndrome	4.95e-05	0.000289	CcSEcCtD
Pomalidomide—Vomiting—Valproic Acid—epilepsy syndrome	4.92e-05	0.000287	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.92e-05	0.000287	CcSEcCtD
Pomalidomide—Insomnia—Topiramate—epilepsy syndrome	4.89e-05	0.000285	CcSEcCtD
Pomalidomide—Rash—Valproic Acid—epilepsy syndrome	4.88e-05	0.000285	CcSEcCtD
Pomalidomide—Dermatitis—Valproic Acid—epilepsy syndrome	4.88e-05	0.000285	CcSEcCtD
Pomalidomide—ABCB1—cerebellum—epilepsy syndrome	4.87e-05	0.00893	CbGeAlD
Pomalidomide—Headache—Valproic Acid—epilepsy syndrome	4.85e-05	0.000283	CcSEcCtD
Pomalidomide—Dyspnoea—Topiramate—epilepsy syndrome	4.82e-05	0.000281	CcSEcCtD
Pomalidomide—Diarrhoea—Pregabalin—epilepsy syndrome	4.79e-05	0.00028	CcSEcCtD
Pomalidomide—Hypersensitivity—Gabapentin—epilepsy syndrome	4.73e-05	0.000276	CcSEcCtD
Pomalidomide—Decreased appetite—Topiramate—epilepsy syndrome	4.7e-05	0.000274	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.66e-05	0.000272	CcSEcCtD
Pomalidomide—Fatigue—Topiramate—epilepsy syndrome	4.66e-05	0.000272	CcSEcCtD
Pomalidomide—Dizziness—Pregabalin—epilepsy syndrome	4.63e-05	0.00027	CcSEcCtD
Pomalidomide—Pain—Topiramate—epilepsy syndrome	4.62e-05	0.00027	CcSEcCtD
Pomalidomide—Constipation—Topiramate—epilepsy syndrome	4.62e-05	0.00027	CcSEcCtD
Pomalidomide—Asthenia—Gabapentin—epilepsy syndrome	4.61e-05	0.000269	CcSEcCtD
Pomalidomide—Nausea—Valproic Acid—epilepsy syndrome	4.6e-05	0.000269	CcSEcCtD
Pomalidomide—Pruritus—Gabapentin—epilepsy syndrome	4.54e-05	0.000265	CcSEcCtD
Pomalidomide—Vomiting—Pregabalin—epilepsy syndrome	4.45e-05	0.00026	CcSEcCtD
Pomalidomide—Feeling abnormal—Topiramate—epilepsy syndrome	4.45e-05	0.00026	CcSEcCtD
Pomalidomide—Rash—Pregabalin—epilepsy syndrome	4.42e-05	0.000258	CcSEcCtD
Pomalidomide—Dermatitis—Pregabalin—epilepsy syndrome	4.41e-05	0.000257	CcSEcCtD
Pomalidomide—Diarrhoea—Gabapentin—epilepsy syndrome	4.39e-05	0.000256	CcSEcCtD
Pomalidomide—Headache—Pregabalin—epilepsy syndrome	4.39e-05	0.000256	CcSEcCtD
Pomalidomide—Body temperature increased—Topiramate—epilepsy syndrome	4.27e-05	0.000249	CcSEcCtD
Pomalidomide—Dizziness—Gabapentin—epilepsy syndrome	4.25e-05	0.000248	CcSEcCtD
Pomalidomide—Nausea—Pregabalin—epilepsy syndrome	4.16e-05	0.000243	CcSEcCtD
Pomalidomide—Vomiting—Gabapentin—epilepsy syndrome	4.08e-05	0.000238	CcSEcCtD
Pomalidomide—Rash—Gabapentin—epilepsy syndrome	4.05e-05	0.000236	CcSEcCtD
Pomalidomide—Dermatitis—Gabapentin—epilepsy syndrome	4.04e-05	0.000236	CcSEcCtD
Pomalidomide—Headache—Gabapentin—epilepsy syndrome	4.02e-05	0.000235	CcSEcCtD
Pomalidomide—Hypersensitivity—Topiramate—epilepsy syndrome	3.98e-05	0.000232	CcSEcCtD
Pomalidomide—ABCB1—brain—epilepsy syndrome	3.95e-05	0.00726	CbGeAlD
Pomalidomide—Asthenia—Topiramate—epilepsy syndrome	3.88e-05	0.000226	CcSEcCtD
Pomalidomide—Pruritus—Topiramate—epilepsy syndrome	3.82e-05	0.000223	CcSEcCtD
Pomalidomide—Nausea—Gabapentin—epilepsy syndrome	3.81e-05	0.000223	CcSEcCtD
Pomalidomide—Diarrhoea—Topiramate—epilepsy syndrome	3.7e-05	0.000216	CcSEcCtD
Pomalidomide—Dizziness—Topiramate—epilepsy syndrome	3.57e-05	0.000209	CcSEcCtD
Pomalidomide—Vomiting—Topiramate—epilepsy syndrome	3.43e-05	0.0002	CcSEcCtD
Pomalidomide—Rash—Topiramate—epilepsy syndrome	3.41e-05	0.000199	CcSEcCtD
Pomalidomide—Dermatitis—Topiramate—epilepsy syndrome	3.4e-05	0.000199	CcSEcCtD
Pomalidomide—Headache—Topiramate—epilepsy syndrome	3.38e-05	0.000198	CcSEcCtD
Pomalidomide—Nausea—Topiramate—epilepsy syndrome	3.21e-05	0.000187	CcSEcCtD
Pomalidomide—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.45e-05	0.000206	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.44e-05	0.000204	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.44e-05	0.000203	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—AKT1—epilepsy syndrome	1.44e-05	0.000203	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	1.41e-05	0.000199	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	1.41e-05	0.000199	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.39e-05	0.000196	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.38e-05	0.000195	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.38e-05	0.000195	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.38e-05	0.000195	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.38e-05	0.000195	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.38e-05	0.000195	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	1.38e-05	0.000195	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADSL—epilepsy syndrome	1.35e-05	0.000191	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—FGF2—epilepsy syndrome	1.34e-05	0.000189	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.33e-05	0.000188	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.33e-05	0.000188	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.33e-05	0.000188	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.33e-05	0.000188	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.33e-05	0.000188	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GLUL—epilepsy syndrome	1.32e-05	0.000187	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.32e-05	0.000186	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	1.3e-05	0.000184	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.3e-05	0.000184	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.29e-05	0.000183	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.28e-05	0.000181	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.26e-05	0.000178	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.26e-05	0.000178	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.26e-05	0.000178	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.26e-05	0.000178	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.26e-05	0.000177	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—RELA—epilepsy syndrome	1.24e-05	0.000176	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.24e-05	0.000175	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.24e-05	0.000175	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.23e-05	0.000174	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.22e-05	0.000172	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	1.22e-05	0.000172	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EIF2AK2—epilepsy syndrome	1.2e-05	0.000169	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.19e-05	0.000169	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AQP1—epilepsy syndrome	1.18e-05	0.000167	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.17e-05	0.000166	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.17e-05	0.000166	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.16e-05	0.000164	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.13e-05	0.00016	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.13e-05	0.00016	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.12e-05	0.000159	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.12e-05	0.000159	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.12e-05	0.000159	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.12e-05	0.000159	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.12e-05	0.000159	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.12e-05	0.000159	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PPIA—epilepsy syndrome	1.11e-05	0.000157	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.1e-05	0.000156	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.1e-05	0.000156	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.1e-05	0.000156	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.1e-05	0.000156	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.1e-05	0.000156	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.1e-05	0.000156	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.09e-05	0.000154	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.08e-05	0.000152	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.08e-05	0.000152	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.07e-05	0.000152	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.07e-05	0.000151	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CHRM3—epilepsy syndrome	1.07e-05	0.000151	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	1.07e-05	0.000151	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP9—epilepsy syndrome	1.06e-05	0.00015	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.05e-05	0.000149	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.05e-05	0.000148	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.05e-05	0.000148	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.04e-05	0.000147	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.03e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.03e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.03e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.03e-05	0.000145	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.02e-05	0.000144	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—UPB1—epilepsy syndrome	1.01e-05	0.000142	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ATIC—epilepsy syndrome	1.01e-05	0.000142	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NEU1—epilepsy syndrome	1.01e-05	0.000142	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	9.98e-06	0.000141	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	9.98e-06	0.000141	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.93e-06	0.00014	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—SRC—epilepsy syndrome	9.77e-06	0.000138	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	9.76e-06	0.000138	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.73e-06	0.000138	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	9.7e-06	0.000137	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADSL—epilepsy syndrome	9.57e-06	0.000135	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	9.54e-06	0.000135	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CA4—epilepsy syndrome	9.54e-06	0.000135	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—VEGFA—epilepsy syndrome	9.51e-06	0.000134	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	9.51e-06	0.000134	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GLUL—epilepsy syndrome	9.38e-06	0.000133	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	9.37e-06	0.000132	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GBE1—epilepsy syndrome	9.37e-06	0.000132	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	9.21e-06	0.00013	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	9.16e-06	0.000129	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.16e-06	0.000129	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.97e-06	0.000127	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	8.92e-06	0.000126	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	8.81e-06	0.000125	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCG2—epilepsy syndrome	8.7e-06	0.000123	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	8.61e-06	0.000122	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	8.57e-06	0.000121	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	8.56e-06	0.000121	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	8.5e-06	0.00012	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	8.5e-06	0.00012	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	8.5e-06	0.00012	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	8.5e-06	0.00012	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	8.5e-06	0.00012	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	8.48e-06	0.00012	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	8.47e-06	0.00012	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	8.42e-06	0.000119	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.36e-06	0.000118	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AQP1—epilepsy syndrome	8.36e-06	0.000118	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NT5E—epilepsy syndrome	8.35e-06	0.000118	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALAD—epilepsy syndrome	8.35e-06	0.000118	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC2A1—epilepsy syndrome	8.21e-06	0.000116	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—JUNB—epilepsy syndrome	8.15e-06	0.000115	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS1—epilepsy syndrome	8.09e-06	0.000114	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	8.03e-06	0.000113	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	7.97e-06	0.000113	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	7.97e-06	0.000113	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	7.8e-06	0.00011	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.78e-06	0.00011	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.78e-06	0.00011	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.78e-06	0.00011	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HBEGF—epilepsy syndrome	7.72e-06	0.000109	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	7.64e-06	0.000108	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADSL—epilepsy syndrome	7.64e-06	0.000108	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.62e-06	0.000108	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	7.6e-06	0.000107	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT3—epilepsy syndrome	7.58e-06	0.000107	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CHRM3—epilepsy syndrome	7.56e-06	0.000107	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	7.56e-06	0.000107	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GLUL—epilepsy syndrome	7.49e-06	0.000106	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	7.49e-06	0.000106	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ADAM10—epilepsy syndrome	7.4e-06	0.000105	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	7.35e-06	0.000104	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	7.24e-06	0.000102	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	7.23e-06	0.000102	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	7.23e-06	0.000102	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—BCHE—epilepsy syndrome	7.21e-06	0.000102	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CDC42—epilepsy syndrome	6.91e-06	9.77e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	6.88e-06	9.72e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	6.87e-06	9.72e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLCB1—epilepsy syndrome	6.8e-06	9.61e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.8e-06	9.61e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TH—epilepsy syndrome	6.77e-06	9.58e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AQP1—epilepsy syndrome	6.68e-06	9.44e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.61e-06	9.35e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	6.44e-06	9.11e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	6.44e-06	9.11e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.41e-06	9.06e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HES1—epilepsy syndrome	6.33e-06	8.95e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCG2—epilepsy syndrome	6.16e-06	8.72e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FYN—epilepsy syndrome	6.15e-06	8.7e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	6.15e-06	8.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	6.15e-06	8.69e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—H2AFX—epilepsy syndrome	6.13e-06	8.67e-05	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—epilepsy syndrome	6.07e-06	8.58e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	6.04e-06	8.53e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	6.04e-06	8.53e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.02e-06	8.51e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	6.01e-06	8.49e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	5.97e-06	8.44e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—YWHAZ—epilepsy syndrome	5.92e-06	8.36e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.89e-06	8.33e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.78e-06	8.17e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.69e-06	8.05e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CCR5—epilepsy syndrome	5.69e-06	8.04e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.67e-06	8.02e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMOX1—epilepsy syndrome	5.65e-06	7.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.62e-06	7.95e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—epilepsy syndrome	5.58e-06	7.89e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.51e-06	7.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCB1—epilepsy syndrome	5.43e-06	7.67e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	5.39e-06	7.62e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	5.31e-06	7.5e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TSC2—epilepsy syndrome	5.29e-06	7.48e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—epilepsy syndrome	5.18e-06	7.32e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.15e-06	7.28e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.14e-06	7.26e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	5.13e-06	7.25e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—BCHE—epilepsy syndrome	5.11e-06	7.22e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GPX1—epilepsy syndrome	5.05e-06	7.13e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	4.92e-06	6.96e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.87e-06	6.89e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6ST—epilepsy syndrome	4.86e-06	6.87e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—epilepsy syndrome	4.82e-06	6.82e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.82e-06	6.81e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TH—epilepsy syndrome	4.8e-06	6.79e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	4.8e-06	6.78e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	4.77e-06	6.74e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.73e-06	6.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.66e-06	6.59e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.66e-06	6.59e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AGT—epilepsy syndrome	4.42e-06	6.25e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—epilepsy syndrome	4.33e-06	6.13e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.31e-06	6.1e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	4.3e-06	6.08e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	4.09e-06	5.79e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—BCHE—epilepsy syndrome	4.08e-06	5.77e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.01e-06	5.67e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—epilepsy syndrome	3.95e-06	5.59e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGF2—epilepsy syndrome	3.93e-06	5.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3.89e-06	5.5e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	3.85e-06	5.44e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TH—epilepsy syndrome	3.83e-06	5.42e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.8e-06	5.37e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.77e-06	5.34e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—POMC—epilepsy syndrome	3.72e-06	5.26e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.7e-06	5.23e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.68e-06	5.2e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTOR—epilepsy syndrome	3.58e-06	5.06e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.58e-06	5.06e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—epilepsy syndrome	3.4e-06	4.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.32e-06	4.69e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.2e-06	4.52e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.16e-06	4.47e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.16e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.15e-06	4.45e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AGT—epilepsy syndrome	3.14e-06	4.43e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—epilepsy syndrome	3.07e-06	4.34e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3.07e-06	4.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3e-06	4.24e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.97e-06	4.2e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TH—epilepsy syndrome	2.96e-06	4.18e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SRC—epilepsy syndrome	2.87e-06	4.06e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.86e-06	4.04e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—POMC—epilepsy syndrome	2.64e-06	3.73e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.5e-06	3.54e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.47e-06	3.49e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.45e-06	3.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.44e-06	3.44e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—epilepsy syndrome	2.41e-06	3.4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.37e-06	3.35e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.2e-06	3.12e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.11e-06	2.98e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.11e-06	2.98e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.93e-06	2.73e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.92e-06	2.72e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.89e-06	2.68e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—epilepsy syndrome	1.78e-06	2.52e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.68e-06	2.38e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.63e-06	2.3e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—epilepsy syndrome	1.49e-06	2.11e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.48e-06	2.1e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.3e-06	1.83e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.06e-06	1.5e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—epilepsy syndrome	8.45e-07	1.19e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.52e-07	9.22e-06	CbGpPWpGaD
